Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Upcoming Dhaman Gujarati movie’s producer Bhupat Bodar presents memento to PM Modi behalf of his Dhaman team Business
  • Chanda Patel Calls Karan Johar ‘Humble Producer Who Champions New Talent’ Lifestyle
  • Mahamandaleshwar Kailashanand Giri met devotees at RPS 12th Avenue, Faridabad Lifestyle
  • Kingston Kickstarts a Gaming Revolution with the New Kingston FURY Lineup in India Technology
  • Does your Child Know Studies can be fun? Press Release
  • AgriGation – Empowering Farmer Collectives – FPO Leadership Summit & Exhibition organised successfully Business
  • Young Achiever of India, Bhavika Maheshwari is bringing about a change through her Spiritual Speeches. English
  • MLA Aslam Shaikh Leads 7th Edition of “Malad Masti,” Mumbai’s Largest Street Festival with 80K Sunday Crowd Entertainment

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Bone & Joint Day 2023: Expert’s Advice to Maintain Healthy Bones and Joints Health
  • JIPSI and Dr. Gaurav Kant Sharma: Revolutionizing Sports Injury Treatment for Athletes Health
  • GenWorks Revolutionizing Women’s Wellness As the Real Freedom Health
  • Morbid obesity must be considered as the top public health priority in India-Shree Skincare & Slimming Center Health
  • Lung Cancer Day: Early Detection & Insights from Leading Experts Health
  • Protyze Launches HYDRA-X: India’s An Advanced Clear Protein with Electrolytes, Creatine & Glutamine. Health

Recent Posts

  • Viral Desai Highlights ‘Waste to Wealth’ and Sustainable Growth at Daman Industrial Expo
  • Active Clothing Co Limited Reports FY26 Performance with Total Income of Rs 318.31 Cr and PAT Growth of 19%
  • First Time in India – CoolSculpting® Elite Launches at Alive Wellness Clinics
  • Avatar Industries Delivers Strong FY26 Financial Performance with Rs 10,287 Lakhs Revenue from Operations
  • Magellanic Cloud Posts Landmark FY26 Yearly Results with Rs 700+ Cr Total Income, and Strong Q4 Results with Rs 205.5 Cr Revenue & 8% Gain in EBITDA

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Excelia Business School makes its first appearance in the QS International Trade Rankings being placed 20th worldwide in the 2024 edition Education
  • Corporate Connect Announces Winners of the 2024 Business Excellence Awards: Celebrating Industry Leaders Business
  • She is India Crowns Madhuri Patle as Mrs. Universe India 2023 Lifestyle
  • Gulf students now welcome in India: New Initiative by GD Goenka, Sector 10, Gurgaon Press Release
  • Actress Rimi Dey Sarkar’s Badmash with Amit Saini touches 3.4 million record-breaking views! Business
  • This Diwali, let your natural-looking brows steal the spotlight Lifestyle
  • Establishing a corridor for Sharda peeth at PoK is our prime objective- Maharshi Keshvananda National
  • Shuchi Ayurveda Launches Comprehensive Ayurvedic Wellness Line Merging Ancient Wisdom with Modern Science Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme